Group items tagged

A short paper on recent advances in synthetic biology. What are the ethical issues and liability potential when just about any biologist will be able to assemble new life forms starting from basic commercially available components?

A brief editorial comment on the problem of conflicts of interest that emerge between companies that sponsor academic research and the recipients of such grants. Of course, when the field is pharmaceuticals, the problems become very big.